YIT Corporation Stock Exchange Release April 27, 2026, at 4:30 p.m. Conveyance of YIT Corporation's own shares under YIT's share-based incentive program. The Board of Directors of ...

April, 2026, at 6.00 p.m EEST. Cityvarasto Has Acquired a Major Property Complex in Turku. Cityvarasto Plc continues its growth in the Turku r ...

The organisational meeting of Framery Group Plc’s Board of Directors elected from among its members Mika Sutinen as the Chair and Ville Koskenvuo as the Deputy Chair of the Board of Directors.

Lumo Homes plc (the "Company") has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Norges Bank (The Central Bank of Norway) on 27 April 2026.

DNA is taking corporate voice channel services to the next level by expanding the DNA Virtual PBX service with new AI ‑assiste d features. The service will be enhanced with automatic caller ...

CSU affects nearly 4 million people in Europe; more than 50% continue to experience debilitating symptoms after conventional antihistamine therapy 3-5 Basel, April 27, 2026 – Novartis announced today ...

Endomines Finland Plc has received a conversion notice related to convertible loan, based on which Wipunen Varainhallinta Oy will convert a total of 1,335,058.90 euros into new shares of Endomines ...

Maritime data and freight management solutions provider, Veson Nautical (Veson), has announced a strategic partnership with ...

NIO to support the automaker’s transition to next-generation 900V electric vehicle platforms. The partnership leverages onsemi’s EliteSiC technology to improve efficiency, performance, and scalability ...

Device brings fine channel control with UART networking, EMI mitigation, diagnostics, and ASIL-B functionality to animated OLED rear lamps, taillights, and DRL lighting MILPITAS, Calif., April 27, ...

The Financial Supervisory Authority (FIN-FSA) has, by a decision issued on 11 March 2026, obliged Nanocredit LTD to disclose information on credits granted by it to the Positive Credit Register. To ...

Novartis today announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) Baby, the first and only antimalarial developed specifically for newborns and ...